321 related articles for article (PubMed ID: 20819983)
1. Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study.
Guo X; Zhai J; Liu Z; Fang M; Wang B; Wang C; Hu B; Sun X; Lv L; Lu Z; Ma C; He X; Guo T; Xie S; Wu R; Xue Z; Chen J; Twamley EW; Jin H; Zhao J
Arch Gen Psychiatry; 2010 Sep; 67(9):895-904. PubMed ID: 20819983
[TBL] [Abstract][Full Text] [Related]
2. Effect of Community-Based Social Skills Training and Tai-Chi Exercise on Outcomes in Patients with Chronic Schizophrenia: A Randomized, One-Year Study.
Kang R; Wu Y; Li Z; Jiang J; Gao Q; Yu Y; Gao K; Yan Y; He Y
Psychopathology; 2016; 49(5):345-355. PubMed ID: 27584836
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of psychosocial intervention for early stage schizophrenia in China: a randomized, one-year study.
Zhang Z; Zhai J; Wei Q; Qi J; Guo X; Zhao J
BMC Psychiatry; 2014 Jul; 14():212. PubMed ID: 25064681
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
6. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive psychosocial therapies for the treatment of schizophrenia.
Patterson TL; Leeuwenkamp OR
Schizophr Res; 2008 Mar; 100(1-3):108-19. PubMed ID: 18226500
[TBL] [Abstract][Full Text] [Related]
8. Supplementing clinic-based skills training with manual-based community support sessions: effects on social adjustment of patients with schizophrenia.
Glynn SM; Marder SR; Liberman RP; Blair K; Wirshing WC; Wirshing DA; Ross D; Mintz J
Am J Psychiatry; 2002 May; 159(5):829-37. PubMed ID: 11986138
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
[TBL] [Abstract][Full Text] [Related]
10. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
[TBL] [Abstract][Full Text] [Related]
11. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.
Subotnik KL; Casaus LR; Ventura J; Luo JS; Hellemann GS; Gretchen-Doorly D; Marder S; Nuechterlein KH
JAMA Psychiatry; 2015 Aug; 72(8):822-9. PubMed ID: 26107752
[TBL] [Abstract][Full Text] [Related]
12. Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.
Chien WT; Mui JH; Cheung EF; Gray R
Trials; 2015 Jun; 16():270. PubMed ID: 26072311
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia.
Velligan DI; Bow-Thomas CC; Huntzinger C; Ritch J; Ledbetter N; Prihoda TJ; Miller AL
Am J Psychiatry; 2000 Aug; 157(8):1317-23. PubMed ID: 10910797
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.
Mohamed S; Rosenheck R; McEvoy J; Swartz M; Stroup S; Lieberman JA
Schizophr Bull; 2009 Mar; 35(2):336-46. PubMed ID: 18586692
[TBL] [Abstract][Full Text] [Related]
15. Two-stage integrated care versus antipsychotic medication alone on outcomes of schizophrenia: One-year randomized controlled trial and follow-up.
She S; Deng Y; Chen Y; Wu C; Yi W; Lu X; Chen X; Li J; Li R; Zhang J; Xiao D; Wu H; Ning Y; Zheng Y
Psychiatry Res; 2017 Aug; 254():164-172. PubMed ID: 28463714
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological predictors of functional outcome in Cognitive Behavioral Social Skills Training for older people with schizophrenia.
Granholm E; McQuaid JR; Link PC; Fish S; Patterson T; Jeste DV
Schizophr Res; 2008 Mar; 100(1-3):133-43. PubMed ID: 18222648
[TBL] [Abstract][Full Text] [Related]
17. Predictors of outcome in brief cognitive behavior therapy for schizophrenia.
Brabban A; Tai S; Turkington D
Schizophr Bull; 2009 Sep; 35(5):859-64. PubMed ID: 19571248
[TBL] [Abstract][Full Text] [Related]
18. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
Byerly MJ; Fisher R; Carmody T; Rush AJ
J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
[TBL] [Abstract][Full Text] [Related]
20. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
